In Massachusetts, researchers found a way to help prevent fibrosis, or scar tissue from developing around medical implant devices. While biomaterial devices have been increasingly replacing metal ones in order to offer a more natural, less rejected type of material for patients’ bodies, biomaterial implants still face fibrosis issues which can impact how well the implant works. But researchers now can fight back against the scar tissue issue by blocking the molecule, CSF1, which signals to macrophages in the body to start building the scar tissue. Once blocked, the body doesn’t create the scar tissue, but interestingly, still allows the body to heal wounds and carry out other important functions. While they tested it on three different biomaterials, researchers believe it will work on any biomaterial and devices such as pacemakers and glucose sensors for diabetes patients.
Latest article
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
DOE awards Hempitecture $8.42 million to boost hemp fiber manufacturing in Tennessee
In Idaho, sustainable building materials firm Hempitecture has been awarded $8.42 million in funding from the U.S. Department of Energy under the Biden-Harris Administration’s...
CJ Biomaterials PHA earns compostability certification
In Massachusetts, CJ Biomaterials, a division of South Korea's CJ CheilJedang, has received certification from the Biodegradable Products Institute (BPI) for its range of...